Tryptophan and serotonin in blood and platelets of depressed patients: Effect of an antidepressant treatment

Salud Mental

Volumn 29, Issue 4, 2006, Pages 1-8

  Moreno, Julia ^a,b   Campos, María G ^c   Lara, Carmen ^a,d   López, Guadalupe ^a   Pavón, Lenin ^a   Hernández, Ma Eugenia ^a   Sentíes, Hector ^a   González Olvera, Jorge ^a   Torruco, Mario ^a   Arango, Ivan ^a   Heinze, Gerardo ^a   Torner, Carlos ^e  

^a INSTITUTO NACIONAL DE PSIQUIATRÍA RAMÓN DE LA FUENTE MUÑIZ   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^c HOSPITAL DE ESPECIALIDADES   (Mexico)

^d BENEMÉRITA UNIVERSIDAD AUTÓNOMA DE PUEBLA   (Mexico)

^e DEPARTAMENTO DE SISTEMAS BIOLÓGICOS   (Mexico)

Author keywords

5 Hydroxitryptamine; Antidepressants; Depression; Platelet; Tryptophan

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; FLUOXETINE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; TRYPTOPHAN;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG BLOOD LEVEL; DRUG EFFECT; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LABORATORY TEST; MALE; PATIENT SELECTION; PSYCHIATRIST; REMISSION; SEMI STRUCTURED INTERVIEW; SEROTONIN BLOOD LEVEL; THROMBOCYTE;

EID: 33749526343     PISSN: 01853325     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. AMERICAN PSYCHIATRIC ASSOCIATION: Diagnostic and Statistical Manual of Mental Disorders (DSM IV). Fourth Edition. American Psychiatric Association, Washington, 1994.
2. ANDERSON GM, FEIBEL FC, COHEN DJ: Determination of serotonin in whole blood, platelet-rich plasma, platelet-poor plasma and ultrafiltrate. Life Sci, 40:1063-1070, 1987.
3. AYMARD N, HONORE P, CARBUCCIA I: Determination of 5-hydroxytryptamine and tryptophan by liquid chromatography in whole blood. Its interest for the exploration of mental disorders. Prog Neuro-Psychopharmacol Biol Psychiat, 18:77-86, 1994.
4. BECK AT, WARD C, MENDELSON M: «Beck Depression Inventory (BDI)». Arch Gen Psychiatry, 4:561-571, 1961.
5. BLARDI P, DE LALLA A, LEO A, AUTERI A, IAPICHINO S et al.: Serotonin and fluoxetine levels in plasma and platelets after fluoxetine treatment in depressive patients. J Clin Psychopharmacol, 22(2):131-136, 2002.
6. BOVIER P, WIDMER J, GAILLARD JM, TISSOT R: Evolution of red blood cell membrane transport and plasma level of tyrosine and L-tryptophan in depressed treated patients according to clinical improvement. Neuropsychobiology, 19:125-134, 1988.
7. CALIL HM: Fluoxetine: A suitable long term treatment. J Clin Psychiatry, 62(suppl), 22:24-29, 2001.
8. CASTROGIOVANNI P, BLARDI P, IAPICHINO S, DE LALLA A et al.: Can serotonin and fluoxetine levels in plasma and platelets predict clinical response in depression? Psychopharmacology Bulletin, 37(2):102-108, 2003.
9. CELADA P, DOLERA M, ALVAREZ E, ARTIGAS F: Effects of acute and chronic treatment with fluvoxamine on extracellular and platelet serotonin in the blood of major depressive patients. Relationship to clinical improvement. J Affect Dissord, 25:243-250, 1992.
10. CLEARE A: Reduced whole blood serotonin in major depression. Depression Anxiety, 5:108-111, 1997.
11. COOK EH, STEIN MA, ELLISON T, UNIS AS, LEVENTHAL BL: Attention deficit hyperactivity disorder and whole blood serotonin levels: Effects of comorbidity. Psychiatry Res, 57:13-20, 1995.
12. CUCCARO ML, WRIGHT, HH, ABRAMSON RK, MARSTELLER FA, VALENTINE J: Whole blood serotonin and cognitive functioning in autistic individuals and their first-degree relatives. J Neuropsychiatry Clin Neurosci, 5:94-101, 1993.
13. DA PRADA M, CESURA AM, LAUNAY JM, RICHARDS JG: Platelets as a model for neurones? Experientia, 44(2):91-182, 1988.
14. HAMILTON M: Development of a rating scale for primary depressive illness Br J Soc Clin Psychol, 6:278, 1967.
15. HEINZE G: Adaptación para Centro y Sudamérica de la version en español den M.I.N.I 5.0.0. Mini International Neuropsychiatric Interview, del DSM-IV, Sheehan DV, Lecrubier Y (ed), 2000.
16. HUGHES CW, PETTY F, SABRI S, KRAMER GI: Whole-blood serotonin in children and adolescents with mood and behaviour disorders. Psychiatry Res, 65:79-95, 1996.
17. KAREGE F, WIDMER J, PHILIPPE BOVIER, GAILLARD JM: Platelet serotonin and plasma tryptophan in depressed patients: Effect of drug treatment and clinical outcome. Neuropsychopharmacology, 10(3):207-214, 1994.
18. KREMER HPH, GOEKOOP JG, VAN KEMPEN GV: Clinical use of the determination of serotonin in whole blood. J Clin Psychopharmacol, 10:83-87, 1990.
19. MANN JJ, MCBRIDE PA, ANDERSON GM, MIECZKOWKI TA: Platelet and whole blood serotonin content in depressed inpatients: correlations with acute and life-time psychopathology. Biol Psychiatry, 32:243-257, 1992.
20. MENYS VC, SMITH CCT, LEWINS P, FARMER RD, NOBLE MI: Platelet 5-hydroxytryptamine is decreased in a preliminary group of depressed patients receiving the 5-hydroxytryptamine re-uptake inhibiting drug fluoxetine. Clin Sci, 91(1):87-92, 1996.
21. MÛCK-SELER D, JAKOVLJEVIC M, DEANOVIC S: Effect of antidepressant treatment on platelet 5-HT content and relation to therapeutic outcome in unipolar depressive patients. J Affect Disord, 23:157-164, 1991.
22. MÛCK-SELER D, JAKOVLJEVIC' M, DEANOVIC' Z: Platelet serotonin in subtypes of schizophrenia and bipolar depression. Psychiatry Res, 38:105-113, 1991.
23. MÛCK-SELER D, JAKOVLJEVIC M, PIVAC N: Platelet 5-HT concentrations and suicidal behaviours in recurrent major depression. J Affect Disord, 39:73-80, 1996.
24. PAPAKOSTAS GI, PETERSEN TJ, FARABAUGH AH, MURAKAMI JL, PAVA JA et al.: Psychiatric comorbidity as a predictor of clinical response to nortriptyline in treatment-resistant major depressive disorder. J clin Psychiatry, 64(11):1357-61, 2003.
25. PLETSCHER A: The 5-hydroxytryptamine system of blood platelets: physiology and pathophysiology. Int J Cardiol, 14:177-188, 1987.
26. QUINTANA J: Platelet serotonin and plasma tryptophan decreases in endogenous depression. Clinical, therapeutic, and biological correlations. J Affective Disord, 24:55-62, 1992.
27. RUSS MJ, ACKERMAN SH, BANAY-SCHWARTZ M, SHINDLEDECKER RD, SMITH GP: Plasma tryptophan to large neutral amino acid ratio in depressed and normal subjects. J Affective Disord; 19:9-14, 1990.
28. SARRIAS MJ, ARTIGAS F, MARTINEZ E, GELPI E, ALVAREZ E et al.: Decreased plasma serotonin in melancolic patients: a study with clomipramine. Biol Psychiatry, 22:1429-1438, 1987.
29. SPREAUX-VAROQUAUX O, GAILLEDREAU J, VANIER B, BOTHUA D, PLAS J et al.: Inicial increase of plasma serotonina: A biological predictor for the antidepressant response to clomipramine? Biol Psychiatry, 40:465-473, 1996.
30. SPINCER LR, JANET WBW, GIBBON M: "Structured Clinical Interview for DSM-III-R-Personality Disorders (SCID-II, 4/1/87)".
31. STAHL SM, CIARANELLO RD, BERGER PA. Platelet serotonin in schizophrenia and depression. Adv Biochem Pychopharmacol, 34:183-198, 1982.
32. STAHL SM: The human platelet. Arch Gen Psychiatry, 34:509-516, 1977.
33. WIRZ-JUSTICE A, PÜHRINGER W: Increased platelet serotonin in bipolar depression and Hypomania. J Neural Transmission, 42:55-62, 1978.